Several tumor-intrinsic factors leading to immune escape and resistance to immune-checkpoint inhibitors have been characterized in cutaneous melanoma, including low tumor antigenicity, disruption of interferon-gamma (IFN-γ) signature, and loss of major histocompatibility complex (MHC) expression. This evidence concerns the gene IFNG and neoplasm.